We are live on ! Find out more
GCM

Galibier Capital Management Portfolio holdings

AUM $300M
1-Year Est. Return 22.03%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
AUM
$251M
AUM Growth
+$31.7M
Cap. Flow
+$28M
Cap. Flow %
11.12%
Top 10 Hldgs %
80.74%
Holding
32
New
1
Increased
15
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$13M
2
NTR icon
Nutrien
NTR
+$7.8M
3
ENB icon
Enbridge
ENB
+$5.27M
4
MFC icon
Manulife Financial
MFC
+$4.84M
5
CM icon
Canadian Imperial Bank of Commerce
CM
+$3.04M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$10.8M
2
AIG icon
American International
AIG
+$1.71M
3
WBA
Walgreens Boots Alliance
WBA
+$1.08M
4
BUD icon
AB InBev
BUD
+$819K
5
PHG icon
Philips
PHG
+$407K

Sector Composition

Rank Sector Weight
1 Financials 33.46%
2 Energy 16.58%
3 Healthcare 13.88%
4 Industrials 13.78%
5 Materials 12.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOYA icon
26
Voya Financial
VOYA
$9.08B
$1.75M 0.7%
32,133
+2,900
+10% +$155K
CL icon
27
Colgate-Palmolive
CL
$74.4B
$1.68M 0.67%
22,908
PCOM
28
DELISTED
Points.com Inc. Common Shares
PCOM
$1.68M 0.67%
153,254
MDT icon
29
Medtronic
MDT
$110B
$1.21M 0.48%
11,150
-103,154
-90% -$10.8M
TMO icon
30
Thermo Fisher Scientific
TMO
$214B
$753K 0.3%
2,585
GOOGL icon
31
Alphabet (Google) Class A
GOOGL
$4.43T
$468K 0.19%
7,660
AIG icon
32
American International
AIG
$42.1B
-32,121
Closed -$1.71M

Similar funds

Galibier Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Galibier Capital Management held 32 positions worth $251M, up 14% from $220M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Galibier Capital Management deployed $28M of net new capital in Q3 2019, opening 1 new position and adding to 15 existing holdings. Its largest new stake was AbbVie: 190,182 shares worth $14.4M.

By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 33% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $10.8M trimmed.

  • Galibier Capital Management's largest Q3 2019 buy was AbbVie: 190,182 shares worth $14.4M.
  • Galibier Capital Management added most to Nutrien in Q3 2019, an estimated $7.8M increase.
  • Galibier Capital Management's biggest Q3 2019 reduction was Medtronic, cutting an estimated $10.8M.
  • Galibier Capital Management fully exited American International in Q3 2019, selling an estimated $1.71M.
  • Galibier Capital Management's ten largest holdings make up 81% of its $251M portfolio in Q3 2019.
  • Galibier Capital Management opened 1 new position and closed 1 in Q3 2019.
  • Galibier Capital Management's portfolio value rose 14% quarter-over-quarter to $251M.

Based on Galibier Capital Management's 13F filing for Q3 2019, filed 8 Nov 2019.